NEUP Neuphoria Therapeutics Inc.

Nasdaq www.neuphoriatx.com


$ 4.50 $ -0.18 (-3.93 %)    

Monday, 03-Nov-2025 19:22:30 EST
QQQ $ 629.78 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.88 $ -2.29 (-0.33 %)
TLT $ 89.68 $ 0.07 (0.08 %)
GLD $ 366.72 $ 0.05 (0.01 %)
$ 4.38
$ 4.58
$ 4.30 x 22
$ 4.52 x 1,949
$ 4.33 - $ 4.60
$ 2.90 - $ 21.40
234,542
na
10.33M
$ 0.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-29-2025 06-30-2025 10-K
2 05-20-2025 03-31-2025 10-Q
3 02-14-2025 12-31-2024 10-Q
4 11-14-2024 09-30-2024 10-Q
5 09-30-2024 06-30-2024 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Neuphoria Therapeutics Inc. ("Neuphoria" or the "Company") (NASDAQ:NEUP), a clinical-stage biotechnology compan...

Core News & Articles

AFFIRM-1 trial did not meet primary endpoint or secondary endpointsCompany to conduct strategic review of portfolio and busines...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION